On 20 April 2020, the EC together with EU Member States and several partners, including EMBL’s European Bioinformatics Institute (EMBL-EBI) and research partners such as ELIXIR, launched a European COVID-19 Data Platform to enable the collection and sharing of reference data and specialised datasets to accelerate COVID-19 research.
The launch of the platform, part of the ERAvsCORONA Action Plan, marks another milestone in the EU's efforts to support researchers in Europe and around the world in the fight against the coronavirus outbreak.
The platform will provide an open European and global environment where researchers can store and share datasets, such as DNA sequences, protein structures, data from pre-clinical research and clinical trials, as well as epidemiological data.
The European COVID-19 Data Platform will consist of two connected components:
The launch of the European COVID-19 Data Platform is a great opportunity for stakeholders involved in research activities related to COVID-19. This initiative enables them to collaborate with other researchers and upload, access and analyse COVID-19 related reference data!
Further information can be found here
